AI

Newly Identified Retinal Biomarker May Reveal Systemic Health Insights

Using AI to characterize the ‘fractal dimension’—or branching patterns—of the vasculature yielded associations with disease prevalence in adults of all ages.
04/16/2024

Attack of the Clones

Artificial intelligence tools may be able to imitate some of a doctor’s skills, but they come up short where it really matters.
04/15/2024

ChatGPT Moderately Accurate in Interpreting Ophthalmic Images

The recent version of the chatbot correctly responded to about two-thirds of multiple choice questions pertaining to ophthalmic cases.
03/06/2024

AI Chatbot Outperforms Retina, Glaucoma Specialists in Disease Management

A new study found that the latest version of ChatGPT could accurately answer questions pertaining to diagnosis and treatment.
02/23/2024

ChatGPT a Long Way from Accurately Educating on Ophthalmic Diseases

Although the AI displayed correct and complete information about many conditions, it still provides potentially harmful details in certain instances.
01/29/2024

ChatGPT Can’t Replace Personalized Patient Education from Doctors

Though there’s potential for AI in eye care, current models produced responses with mixed accuracy in a new study.
07/25/2023

Upcoming Events

December 5, 2024

Rethinking Dry Eye Disease: A Contemporary Approach to a Complex Condition
Location: Virtual
Presenters: Nate Lighthizer, OD, and Dagny Zhu, MD
Webinar: 9:00pm ET

Sponsored by Bausch + Lomb

Register here

December 6-7, 2024

West Coast Optometric Glaucoma Symposium
Location: Westin Carlsbad, Carlsbad, California
Program Co-Chairs: Murray Fingeret, OD, and Robert N. Weinreb, MD
Earn up to 12 LIVE COPE Credits (accreditation pending)

Register here

December 7-8, 2024

Retina Update 2024
Location: Westin Carlsbad, Carlsbad, California
Program Chairs: Mohammad Rafieetary, OD, and Steven Ferrucci, OD
Earn up to 11 LIVE COPE credits (accreditation pending)

Register here